alt
// Mission
Use Real World Outcomes®
to change the paradigm of care
for people living with chronic
pain by getting them the right
therapy at the right time.
quote
"Celéri Health’s mission is to use Real World Outcomes® to change the paradigm of care for people living with chronic pain by getting them the right therapy at the right time."
Sean McCrossen
President & CEO
// Key people
The team
Sean McCrossen
President & CEO
Read more
Sean McCrossen
President & CEO

Sean is currently the Managing Partner of SHP, LLC Advising Innovative clients in healthcare, health-tech and provider companies on matters of strategic importance at the board and c-suite levels. He is a seasoned operational executive in both public and private environment. That operational experience has been coupled with a deep transactional track record of accomplishment across verticals.

Among those experiences are founding companies and / or advising companies in Heath-data, Health-tech, Behavioral Health, PMR, Oncology, Specialty group practice and Revenue Cycle. Of note is Firstlight Intelligence a company Sean built through innovative technology and resourcing to construct the first intricate real time landscape of the entire US healthcare provider market which later became the “data backbone” of several health data companies.

Prior to SHP Sean served as VP Corporate Development for Foster Management a PE fund investing throughout the healthcare industry and in allied support services. Sean built through acquisition some of the more successful companies that “went public” during his tenure. This experience was buttressed by several years as a med-surg and behavioral hospital administrator focusing on building alternate care delivery systems.

Celéri Health - Opioid Risk Assessment Tool | Promis measures
Michael Fishman, MD, MBA
Medical Director + Co Founder
Read more
Celéri Health - Opioid Risk Assessment Tool | Promis measures
Michael Fishman, MD, MBA
Medical Director + Co Founder

Dr. Fishman is a practicing pain specialist in the Philadelphia area with a diverse clinical practice that includes innovation, clinical research, and the evidence-based treatment of painful conditions.

At Celéri Health, Michael is committed to redefining the outcomes metrics we use to measure response to pain care and neuromodulation through the clinical development of the Real World Outcomes platform. Dr. Fishman received his undergraduate degree at Franklin & Marshall College, his medical degree at Jefferson Medical College and a Masters of Business Administration at Drexel University’s LeBow College of Business. He also completed his internship at Lankenau Hospital, residency in anesthesiology at Yale University, and pain medicine fellowship at Stanford University. He is on the Board of Directors of the North American Neuromodulation Society and is a key opinion leader in the field of neuromodulation and interventional pain care, frequently publishing and presenting his work on national and international podiums.

 

Celéri Health - Opioid Risk Assessment Tool | Promis measures
Jason Pope, MD, DABPM, FIPP
Medical Director + Co Founder
Read more
Celéri Health - Opioid Risk Assessment Tool | Promis measures
Jason Pope, MD, DABPM, FIPP
Medical Director + Co Founder

Dr Pope is the President & CEO of Evolve Restorative Center in Northern California. He is the President of the California Society of Interventional Pain Physicians and serves the North American Neuromodulation Society (NANS) as an ex-officio director at large for the International Neuromodulation Society, is the co-chair for the CME committee, the co-chair for the pre-conference training workshop in the biennial meeting in Sydney, Australia, and the co-chair for the Young Neuromodulation Committee.  He also is the co-founder of the Special Interest Group in Neuromodulation for the American Society of Regional Anesthesia (ASRA). Dr Pope has published over 100 peer-reviewed articles while working with medical device start up companies and established industry partners to provide strategic planning and execution for patient-centric adoption and supportive patient outcomes.

Cam Teems
Chief Commercial Officer
Read more
Cam Teems
Chief Commercial Officer

Cam is a disease leader striving to improve healthcare by sharing the broken story of the patient journey, hoping to ultimately change the patient experience through revolutionary & bold acts. Areas of interest include ground-breaking healthcare technology with an emphasis on deep care management in complex, chronic & rare diseases, social determinants, disparities/inequality, hot spotting, coaching and anything changing the status quo.

Celéri Health | Terms of Service | Patient-reported Outcomes
David Tannenbaum
CTO and Co-Founder
Read more
Celéri Health | Terms of Service | Patient-reported Outcomes
David Tannenbaum
CTO and Co-Founder

David has more than a decade of experience leading and managing successful technology companies. David was the Founder & CTO of Loan Ecosystem Online. Prior to founding Loan Ecosystem Online, David was CTO of PulsePoint and BlueCava which were acquired by WebMD and Qualia respectively. David was the Chief Technology Officer of LiftDNA, a leading SSP (sell-side platform), before it was acquired by OpenX in February 2012. Prior to LiftDNA, David served as the Chief Architect of mOcean, the industry leading solution to mobile ad serving which was acquired by Pubmatic.

David began his career as a Systems Engineer at Sun Microsystems and was later recruited by TimeSys as one of its first employees to work on Real Time Linux and Java. David graduated with a degree in Computer Science Engineering from the University of Pennsylvania.

Celéri Health - Opioid Risk Assessment Tool | Promis measures
Chris Mellor, MBA
VP of Operations
Read more
Celéri Health - Opioid Risk Assessment Tool | Promis measures
Chris Mellor, MBA
VP of Operations

Chris graduated with a BS in Finance & Operations Management from the University of Delaware and subsequently spent 6 years working on JP Morgan’s US Treasury Desk as a trading assistant. Chris traded NYC for Chapel Hill where he received is MBA from University of North Carolina with a concentration in Entrepreneurship. Upon graduation and prior to joining Celéri Health, Chris was drawn to the world of entrepreneurship and found himself working for a digital start-up based in Cape Town, South Africa helping develop market entry strategy and leading US Operations.

John Buck
VP Administration
Read more
John Buck
VP Administration

John has extensive experience in corporate finance, executive leadership, and private equity.  He has held operating roles at Target RWE, Dodge Data & Analytics, and IMS Health (now IQVIA).  John co-led the middle-market investment team at DW Partners and was a member of the investment teams at Versa Capital Partners and Cerberus Partners.  John began his career as a Project Engineer at the ECRI Institute, a healthcare consultancy and think tank.  He graduated from the University of Pennsylvania with a BSE in Bioengineering and received an MBA with Honors, Beta Gamma Sigma, from Temple University.  He also holds an MA in Theology from Villanova University where he is an adjunct professor in the Theology Department.

Become part of the team
We are always open to connecting with the top talent in digital healthcare. It's an exciting time to join Celéri Health, please reach out if you are interested!
// partners

Companies already using our data
Celéri Health - Opioid Risk Assessment Tool | Promis measures
Celéri Health - Opioid Risk Assessment Tool | Promis measures
Celéri Health - Opioid Risk Assessment Tool | Promis measures
Celéri Health - Opioid Risk Assessment Tool | Promis measures
Celéri Health - Opioid Risk Assessment Tool | Promis measures
Celéri Health - Opioid Risk Assessment Tool | Promis measures
Celéri Health - Opioid Risk Assessment Tool | Promis measures
Celéri Health - Opioid Risk Assessment Tool | Promis measures
Celéri Health - Opioid Risk Assessment Tool | Promis measures
Celéri Health - Opioid Risk Assessment Tool | Promis measures
Celéri Health - Opioid Risk Assessment Tool | Promis measures
Celéri Health - Opioid Risk Assessment Tool | Promis measures
Schedule demo
Please schedule a time that works for you and we will connect with you to provide a demo.
Contact
Let us know how to reach you and we will be in touch within 24 hours.
Ask us anything
Talk to us
Let us know how to reach you and we will be in touch within 24 hours
Apply now
File type: doc, docx, pdf, xls, xlsx. File size: 10Mb.
sent
Request sent
"Thank you for your inquiry, we will be in touch within 24 hours."
Done